Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 9Fallopian Tube Neoplasms 8Breast Neoplasms 6Neoplasms 5Carcinoma, Ovarian Epithelial 5Recurrence 3Prostatic Neoplasms 3Endometrial Neoplasms 3Small Cell Lung Carcinoma 2Metastatic Castration Resistant Prostate Cancer 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor, Unspecified, Adult 1Solid Tumor 1Prostate Cancer Metastatic 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related 1Lung Neoplasms 1Genital Neoplasms, Male 1Genital Neoplasms, Female 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Advanced Solid Tumors 1Advanced Solid Tumor 1Advanced Gastric Cancer 1Adenocarcinoma, Clear Cell 1Adenocarcinoma of Lung 1

Interventions

toripalimab 6Injections 4tislelizumab 3sintilimab 3pembrolizumab 3cediranib 3glumetinib 2apatinib 2PM 01183 2Midazolam 2Irinotecan 2Gemcitabine 2Drug Therapy 2Digoxin 2Bupropion 2talazoparib 1spartalizumab 1sonidegib 1sitravatinib 1serabelisib 1sapanisertib 1rucaparib 1repaglinide 1penpulimab 1palbociclib 1lenvatinib 1fluzoparib 1erdafitinib 1entrectinib 1dactolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Solid Tumor × rucaparib × Clear all
NCT03499444 2023-06-09

A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor

pharmaand GmbH

Phase 1 Completed
29 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡